1. Market Research
  2. > Pathology
Customer Support

Talk to Sam

+1 646 893 5945

About 11000 reports for Lymphoma (page 1)

Download Unlimited Documents from Trusted Public Sources

View report >

Lymphoma Statistics in the UK

  • January 2018
  • 6 pages

(observed and ##. ##% five years from a lymphoma diagnosis in 2009-2013.

  • Cancer
  • Lymphoma
  • United Kingdom
  • Demographic
View report >

Lymphoma Statistics

  • December 2019
  • 11 pages

Survival of patients with Burkitt lymphoma by sex.

  • Cancer
  • Lymphoma
  • Pathology
  • Germany
  • United States
View report >

Lymphoma Statistics

  • December 2019
  • 12 pages

Survival of patients with Non-follic. lymphoma by sex.

  • Cancer
  • Lymphoma
  • Pathology
  • Germany
  • United States
View report >

Lymphoma Statistics

  • December 2019
  • 12 pages

Survival of patients with Follic. lymphoma by sex.

  • Cancer
  • Lymphoma
  • Pathology
  • Germany
  • United States
View report >

Lymphoma Statistics

  • December 2019
  • 13 pages

Survival of patients with MALT lymphoma by sex.

  • Cancer
  • Lymphoma
  • Pathology
  • Germany
  • United States
View report >

Therapy Market in Washington (USA)

  • November 2019
  • 12 pages

Lymphoma is a diverse group of cancers that originate from B-, T- or NK- cells.

  • Lymphoma
  • Pathology
  • Therapy
  • United States
  • BeiGene, Ltd.
View report >

Lymphoma Statistics in the US

  • July 2017
  • 9 pages

These include studies in patients with relapsed or refractory Hodgkin lymphoma and CD##-expressing relapsed or refractory non-Hodgkin lymphomas, including T-cell lymphomas, diffuse large B-cell lymphoma (DLBCL), and other rare subtypes of Bcell malignancies, including mediastinal B-cell

  • Lymphoma
  • United States
  • Immunomedics, Inc.
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
View report >

Lymphoma Statistics

  • December 2019
  • 13 pages

Survival of patients with Mantle cell lymphoma by sex.

  • Cancer
  • Lymphoma
  • Pathology
  • Germany
  • United States
View report >

Lymphoma Statistics and Therapy Market in the US - Forecast

  • July 2017
  • 8 pages

The company intends to initiate new combination study in patients with follicular lymphoma in 2017.

  • Lymphoma
  • Therapy
  • United States
  • Epizyme, Inc.
  • GlaxoSmithKline plc
View report >

Lymphoma Statistics in Japan - Forecast

  • April 2019
  • 19 pages

In the case of Japanese patients, malignant lymphomas are mostly (##%) of the NHL type.

  • Lymphoma
  • Japan
  • Astellas Pharma Inc.
  • Onconova Therapeutics, Inc.
  • SymBio Pharmaceuticals Limited
View report >

Medical Biotechnology Industry in Canada

  • August 2019
  • 76 pages

Lymphoma Canada is Canada' s only national organization focused entirely on lymphoma.

  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • Canada
View report >

Hospital Forecast Statistics in the US

  • December 2017
  • 34 pages

GOV CHART ##: LYMPHOMA & NON-ACUTE LEUKEMIA W/ MAJOR COMPLICATIONS OR COMORBIDITIES CHART ##: LYMPHOMA & NON-ACUTE LEUKEMIA W/ MAJOR COMPLICATIONS OR COMORBIDITIES (CONTINUED) CHART ##: LYMPHOMA & NON-ACUTE LEUKEMIA W/ COMPLICATION OR COMORBIDITI

  • Hospital
  • Lymphoma
  • United States
  • Gilead Sciences, Inc.
  • Jefferies LLC
View report >

Lymphoma Statistics in the US

  • December 2018
  • 30 pages

Abstract ##, ASH 2018 * ORR - Overall Response Rate; CR - Complete Response; PR - Partial Response; SD - Stable Disease; PD - Progressive Disease ** MCL - Mantle Cell Lymphoma - SLL Small Lymphocytic Lymphoma Highly active in advanced follicular lymphoma and in FL patien

  • Cancer
  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody
  • United States
View report >

Lymphoma Statistics in the US

  • January 2018
  • 34 pages

**Mantle cell lymphoma (n=##), marginal zone lymphoma (n=##), small lymphocytic lymphoma (SLL; n=##).

  • Cancer
  • Lymphoma
  • Pathology
  • Therapy
  • United States
View report >

Lymphoma Statistics in the US

  • January 2018
  • 13 pages

DLBCL, diffuse large B-cell lymphoma.

  • Cancer
  • Lymphoma
  • United States
  • Demographic
View report >

Medical Biotechnology Industry in Canada

  • January 2019
  • 85 pages

Lymphoma Canada is Canada' s only national organization focused entirely on lymphoma.

  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Therapy
  • Canada
View report >

Therapy Market in China

  • March 2018
  • 39 pages

According to research article " Distribution pattern of lymphoma subtypes in China: A nationwide multicenter study of ##, ## cases", DLBCL accounts for c. ##% of total lymphoma cases, while FL represents c. ##% of all lymphoma cases.

  • Lymphoma
  • Therapy
  • China
  • Sino Biopharmaceutical Limited
  • SWS Research Co., Ltd.
View report >

Cancer Statistics in the US

  • January 2017
  • 28 pages

Estimated New Cases of Lymphoma, by Gender, 2017 ## Table ##.

  • Cancer
  • Leukemia
  • Lymphoma
  • United States
  • American Cancer Society, Inc.
View report >

Cancer Statistics in the UK

  • January 2017
  • 9 pages

This includes leukaemia, lymphoma, and myeloma.

  • Cancer
  • Leukemia
  • Lymphoma
  • Pathology
  • United Kingdom
View report >

Cancer Statistics

  • February 2020
  • 66 pages

Salivary gland Polycythaemia vera Oropharynx Other lymphomas Thymus Eye Nose, nasal cavities, middle ear and accessory sinuses Larynx Other endocrine glands Skin of anus (including perineum, perianal skin) Nasopharynx Malignancy of histiocytes and accessory lymphoid cells Unspecified sites

  • Cancer
  • Lymphoma
  • Pathology
  • Australia
  • Demographic

Immuno-Oncology Market, By Type [mAb (Naked, Conjugate), Cancer Vaccines, Immune Checkpoint Inhibitors (PD-1, PD-L1, CTLA-4]), By Application (Lung, Melanoma, Leukemia, Lymphoma) - Global Forecast to 2024

  • $ 3000
  • May 2020
  • 195 pages

Global Immuno-Oncology Market, By Major Indications ##. ## Head & Neck Cancer ##. ## Lung Cancer ##. ## Melanoma ##. ## Lymphoma ##. ## Leukemia ##. ## Others ##.

  • Lymphoma
  • Oncology
  • Therapy
  • World
  • Market Size

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on